HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Eduardo Blanco Selected Research

Stroke (Strokes)

3/2014The systemic administration of oleoylethanolamide exerts neuroprotection of the nigrostriatal system in experimental Parkinsonism.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Eduardo Blanco Research Topics

Disease

5Hypoxia (Hypoxemia)
10/2018 - 09/2013
5Asphyxia (Suffocation)
07/2017 - 09/2013
4Neuroinflammatory Diseases
01/2019 - 01/2016
4Nervous System Diseases (Neurological Disorders)
07/2017 - 03/2014
4Cocaine-Related Disorders (Cocaine Addiction)
07/2016 - 01/2013
3Gliosis
10/2018 - 01/2015
3Ischemia
10/2018 - 01/2016
1Inflammation (Inflammations)
10/2018
1Substance-Related Disorders (Drug Abuse)
03/2017
1Neurodegenerative Diseases (Neurodegenerative Disease)
03/2017
1Alcoholism (Alcohol Abuse)
04/2016
1Brain Ischemia (Cerebral Ischemia)
01/2015
1Hypothermia
05/2014
1Brain Hypoxia-Ischemia (Hypoxia Ischemia, Brain)
05/2014
1Stroke (Strokes)
03/2014
1Parkinsonian Disorders (Parkinsonism)
03/2014
1Parkinson Disease (Parkinson's Disease)
03/2014
1Alzheimer Disease (Alzheimer's Disease)
01/2014
1Cognitive Dysfunction
01/2014
1Mental Disorders (Mental Disorder)
11/2013
1Anxiety Disorders (Anxiety Disorder)
11/2013
1Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder)
09/2013
1Schizophrenia (Dementia Praecox)
09/2013
1Obesity
01/2013
1Body Weight (Weight, Body)
01/2013

Drug/Important Bio-Agent (IBA)

5EndocannabinoidsIBA
07/2017 - 01/2013
4EnzymesIBA
07/2017 - 01/2013
3oleoylethanolamideIBA
01/2019 - 03/2014
3LipidsIBA
01/2018 - 01/2013
3Neuroprotective AgentsIBA
01/2018 - 05/2014
3Proteins (Proteins, Gene)FDA Link
01/2017 - 01/2013
3Cocaine (Cocaine HCl)IBA
07/2016 - 09/2013
2Ethanol (Ethyl Alcohol)IBA
01/2019 - 11/2018
2CannabinoidsIBA
11/2018 - 01/2013
2palmidrolIBA
10/2018 - 01/2018
2Peroxisome Proliferator-Activated Receptors (PPAR)IBA
01/2018 - 03/2014
2Glutamic Acid (Glutamate)FDA Link
03/2017 - 01/2017
1Glucose (Dextrose)FDA LinkGeneric
10/2018
1Lysophosphatidic Acid ReceptorsIBA
04/2016
1PPAR alphaIBA
01/2016
1ElementsIBA
01/2016
1LigandsIBA
01/2016
1Actins (F Actin)IBA
05/2014
1Oxygen (Dioxygen)IBA
01/2014
1Amyloid (Amyloid Fibrils)IBA
01/2014
1Biomarkers (Surrogate Marker)IBA
11/2013
1Dopamine (Intropin)FDA LinkGeneric
09/2013
1HydrolasesIBA
01/2013
1Lipoprotein Lipase (Diacylglycerol Lipase)IBA
01/2013
1Monoacylglycerol LipasesIBA
01/2013
1Phospholipase DIBA
01/2013
1CarbohydratesIBA
01/2013
1lysophosphatidic acidIBA
01/2013
1CB1 Cannabinoid Receptor (CB1 Receptor)IBA
01/2013
1phosphatidylethanolamineIBA
01/2013
1AM 251 (AM251)IBA
01/2013
1Fatty Acids (Saturated Fatty Acids)IBA
01/2013

Therapy/Procedure

2Cesarean Section (Caesarean Section)
01/2014 - 09/2013
1Therapeutics
01/2013